Athenex, Inc.
ATNXDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001300699
Athenex, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on May 8, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $2.43M in total; no superinvestor held it.
Holders of 5% or more of ATNX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Athenex, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Athenex, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Athenex, Inc., newest first.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Oct 12, 2021 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| May 27, 2021 | IP Group PLC | 13GOld format | – | New | – | SEC |
| Apr 12, 2021 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Jan 28, 20215:56 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Athenex, Inc. shares.
No Form 144 notices for Athenex, Inc. are on file.